Solana Company (HSDT) Financial Analysis & Valuation | Quarter Chart
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the... more
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellne... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $131.95M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Dane Carl Andreeff |
| IPO Date | 2014-06-27 | CAGR | — |
| Employees | 21 | Website | solana.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.01% | Total Yield | 0.01% |
HSDT chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $158.17M | P/E | -0.07 | Forward P/E | -20.55 | PEG | — |
| P/S | 52235924.27 | P/B | 5069762.97 | P/CF | -56162548.46 | P/FCF | -41739990.17 |
| Sales | $12.07M | Sales 1Y | 3992.2% | Sales 3Y | 1328.64% | Sales 5Y | 2430.82% |
| EPS | $-30.32 | EPS 1Y | 285.99% | EPS 3Y | 70.61% | EPS 5Y | -86.06% |
| Sales QoQ | -30.24% | EPS QoQ | -72.31% | Sales QoQ Avg | 527.51% | EPS QoQ Avg | 102.12% |
| Gross Margin | 95.53% | Operating Margin | -399.33% | Profit Margin | -1302.78% | ROCE | -27.72% |
| ROA | -89% | ROE | -123% | Altman Z Score | 5.13 | Piotroski Score | 3 |
| Current Ratio | 13.31 | Quick Ratio | 13.31 | Cash Ratio | 1.69 | Op. CF Ratio | — |
| Debt/Equity | — | Debt/Assets | — | Lt Debt/Equity | — | Lt Debt/Cap. | — |
| Intrst Cov. | -48207 | Inventory Turnover | — | Asset Turnover | 0.07 | Receivables Turnover | — |
| Enterprise Value | $158.17M | P/E Ratio | -0.07 |
| Forward P/E | -20.55 | PEG Ratio | — |
| P/S Ratio | 52235924.27 | P/B Ratio | 5069762.97 |
| P/CF Ratio | -56162548.46 | P/FCF Ratio | -41739990.17 |
| EPS | $-30.32 | EPS Growth 1Y | 285.99% |
| EPS Growth 3Y | 70.61% | EPS Growth 5Y | -86.06% |
| Revenue Growth 1Y | 3992.2% | Gross Margin | 95.53% |
| Operating Margin | -399.33% | Profit Margin | -1302.78% |
| ROE | -123% | ROA | -89% |
| ROCE | -27.72% | Current Ratio | 13.31 |
| Quick Ratio | 13.31 | Cash Ratio | 1.69 |
| Debt/Equity | — | Interest Coverage | -48207 |
| Altman Z Score | 5.13 | Piotroski Score | 3 |
Solana Company (HSDT) valuation & financials
Solana Company (HSDT) has a market capitalization of $131.95M and trades at a price-to-earnings ratio of -0.1. It operates in the Healthcare sector (Medical - Devices).
Solana Company's revenue grew +3992.2% over the last year.
Solana Company's next earnings report is scheduled for November 17, 2026 (provider scheduled date); analysts estimate EPS of $0.02. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)